We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

071050:KRXKorea Investment Holdings Co., Ltd. Analysis

Data as of 2026-05-29 - not real-time

₩237,500.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Korea Investment Holdings (071050) trades at a forward P/E of 6.15, well below the industry average of 16.58, indicating a sizable valuation discount. The stock offers a 3.64% dividend yield with a modest 20.5% payout ratio, suggesting dividend sustainability. Technicals show a mixed picture: price sits below the 20‑day (252,700) and 50‑day (242,600) SMAs but remains above the 200‑day SMA (190,589), while the RSI of 44.3 is neutral and the MACD is bearish. Volatility is elevated at 61.7% over 30 days and beta is 1.44, implying higher market sensitivity. The market sentiment index reads Extreme Greed (93.54), aligning with the current upside potential of roughly 36% against the identified support at 220,000 and resistance near 297,000. Fundamentally, the firm delivers strong operating margins (~78.8%) and a healthy ROE of 21.7%, despite a recent revenue decline of -7.1%. Overall, the combination of deep valuation discount, attractive dividend, solid profitability, and a bullish long‑term trend supports a positive outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • Stable volume and strong dividend yield
  • Valuation discount offering limited upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued forward P/E versus peers
  • Robust operating margins and ROE
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained profitability and cash generation
  • Significant upside potential relative to support levels
  • Strong dividend sustainability and favorable market sentiment

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin48.89%
P/E Ratio6.1
ROE21.73%
ROA1.91%
Industry P/E16.6

Technical Analysis

TrendBullish
RSI44.3
Support₩220,000.00
Resistance₩297,000.00
MA 20₩252,700.00
MA 50₩242,600.00
MA 200₩190,589.00
MACDBearish
VolumeStable
Fear & Greed Index93.54

Valuation

Target Price₩323,538.47
Upside/Downside36.23%
GradeUndervalued
TypeBlend
Dividend Yield3.64%

Risk Assessment

Beta1.44
Volatility61.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.